1Suppliers
3Customers
3Debt Items
20Related Chains

NeurAxis, Inc. Suppliers

TickerNameConfidenceEvidence
CRAIG-HALLUM-CAPITAL-GROUP-LLC CRAIG-HALLUM-CAPITAL-GROUP-LLC 92% As previously disclosed, on August 29, 2025, the Company entered into an At The Market Offering Agreement (the “Agreement”) with Craig-Hallum Capital Group LLC (the “Sales Agent”) under which the Com…

NeurAxis, Inc. Customers

TickerNameConfidenceEvidence
MASIMO MASIMO 90% Masimo paid a one-time fee of $250,000.
ORANY ORANY 72% alid and scientifically supported approach to the treatment of neurological conditions, and accordingly, we expect for competition in the non-implanted space to grow in the future. While many compani…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from NRXS graph: alid and scientifically supported approach to the treatment of neurological conditions, and accordingly, we expect f…

NeurAxis, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
NRXS-DEBT-11375 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.
NRXS-DEBT Debt stack $426,610 90% Market cache reports total debt of $426,610.
NRXS-DEBT-11374 Warrants outstanding: 0.01 90% xbrl warrant detail from xbrl 2025-12-31.

NeurAxis, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for NeurAxis, Inc..

NeurAxis, Inc. Ownership

HolderNameConfidenceEvidence
NRXS-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 26 tracked holders.

NeurAxis, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ORANY ORANGE 100.00 1 ['customer']
MASIMO MASIMO 60.75 1 ['receiving']
AMZE Amaze Holdings, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
CORT Corcept Therapeutics Incorporated 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2